Skip to main content
Metropolis Healthcare Limited logo

Metropolis Healthcare Limited — Investor Relations & Filings

Ticker · METROPOLIS ISIN · INE112L01020 LEI · 335800SD5OOGR1D97215 BSE.NS Human health and social work activities
Open in API
Filings indexed 745 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IN India
Listing BSE.NS METROPOLIS

About Metropolis Healthcare Limited

https://www.metropolisindia.com/

Metropolis Healthcare Limited is a multinational provider of diagnostic services, offering an extensive menu of over 4,000 clinical laboratory tests and profiles. The company specializes in pathology, radiology, and molecular diagnostics, covering diverse medical fields such as oncology, neurology, and genetics. It operates a vast network of clinical laboratories and patient touchpoints, utilizing automated systems and advanced diagnostic technologies to ensure precision and rapid turnaround times. Services include routine screenings, specialized diagnostic investigations, and comprehensive wellness packages tailored for individual patients, healthcare providers, and corporate entities. The organization adheres to rigorous international quality benchmarks, with numerous facilities maintaining NABL and CAP accreditations to support informed clinical decision-making.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Regulatory Filings Classification · 81% confidence The document is a submission to stock exchanges under Regulation 24A of SEBI LODR, enclosing an Annual Secretarial Compliance Report prepared by the company’s secretarial consultant. It is neither an annual or interim financial report nor an earnings release or proxy. It is a regulatory compliance filing/certification. Therefore, it best fits into the “Regulatory Filings” category (RNS).
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 63% confidence The document is a formal intimation to stock exchanges (BSE/NSE) disclosing the schedule of analyst/institutional investor meetings under SEBI Listing Regulations (Regulation 30(6)). It contains no financials, results, or presentation materials—simply a compliance notice. It does not constitute an earnings release, annual report, investor presentation, or any substantive report type. This is a regulatory announcement/fallback, so it best fits “Regulatory Filings” (RNS).
2026-05-27 English
Schedule of Analyst / Institutional Investor Meeting
Regulatory Filings Classification · 88% confidence The document is a compliance announcement under SEBI Listing Regulations (Reg. 30(6)), notifying stock exchanges of upcoming analyst/investor meetings. It contains no financial results, report attachments, or officer certifications. It is a general regulatory filing for continuous disclosure and does not fit into any specific financial report category, so it falls under “Regulatory Filings” (RNS).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 87% confidence The document is an earnings conference call transcript for Q4 FY26, including moderator and management discussion, Q&A format. This matches the definition of a Call Transcript (CT).
2026-05-19 English
Transcript of Q4 FY26 earnings conference call held on Thursday, May 14, 2026
Call Transcript Classification · 95% confidence The document is a formal submission to stock exchanges containing the full transcript of Metropolis Healthcare’s Q4 FY26 earnings conference call, including management remarks and Q&A. This aligns directly with the definition of a Call Transcript (Code: CT).
2026-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 82% confidence The document is a regulatory disclosure letter under SEBI LODR notifying stock exchanges that the audio recording of the Q4 FY26 earnings conference call is available on the company’s website. It does not include actual financial results, management commentary, or full call transcript, nor is it the report itself—it is a general regulatory announcement. This falls under the catch-all Regulatory Filings category.
2026-05-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.